1ISG-008 Economic impact of the use of biosimilar infliximab in a second-level hospital
Author(s) -
AB Morillo Mora,
V González Rosa,
MI Sierra Torres
Publication year - 2018
Publication title -
pubmed central
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.8
Subject(s) - biosimilar , infliximab , medicine , pharmacy , observational study , vial , total cost , retrospective cohort study , hospital pharmacy , emergency medicine , family medicine , business , accounting , chemistry , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom